Dr. Yaw Twum-Barima

He is currently the Chief of Medicine at Trenton Memorial Hospital in Canada and Consultant Physician of Belleville General Hospital. This Endocrinology Specialist is also The Medical Director of the Diabetic Education Clinics at Belleville General Hospital and Trenton Memorial Hospital.

The man and his game.

1. PERSONAL DATA

Date of Birth: January 5th, 1949
Citizenship: Canadian
Marital Status: Married. (Margaret)
Children: Nana (1977), Maame (1979), Tachiwa (1982)

Address:

Offices:
222-245 Dundas Street East
Belleville, On K8N 1E6

20 Joseph Street
Trenton, On K8V 4A1

2. ACADEMIC & PROFESSIONAL QUALIFICATIONS

• MB, Ch.B. (Medicine) - 1974 (University of Ghana Medical School)
• MSc (Clinical Pharmacology) - 1981 (University of Western Ontario)
• FRCPC (Fellow, Royal College Of Physicians Canada) - 1983
• Sub-specialty Training in Endocrinology & Metabolism (Ottawa Civic Hospital) - July 1983 - June 1984

3. CURRENT POSITION

• Chief of Medicine, Trenton Memorial Hospital
• Consultant Physician, Belleville General Hospital
• Medical Director, Diabetic Education Clinics at Belleville General Hospital & Trenton Memorial Hospital
• Member of Eastern Ontario Diabetic Advisory Committee
• Member of Diabetes Health Management Advisory Group of Bayer Canada
• Co-Investigator Glycemic Control Evaluation: National Efficacy and Safety of an Insulin Resistance-Reducing Agent Study - 1998

4. PROFESSIONAL MEMBERSHIPS

• Fellow, Royal College Of Physicians of Canada
• Licentiate, Medical Council of Canada
• Member, Ontario Medical Association
• Member, Endocrine Society, USA and Canada
• Member, Scientific and Clinical Section Canadian Diabetes Association
• Member, American Diabetes Association
• Member, Canadian Society of Clinical Pharmacology
• Member, International Diabetes Federation

5. AWARDS & HONORS

• London General Certificate of Education (Advanced Level) with Distinction in Physics, Chemistry, and Zoology, 1969.
• Direct Entry into Ghana Medical School, 1969
• Astra Prize for best presentation by trainee in Clinical Pharmacology, Canadian Society for Clinical Investigation, Ottawa, Canada, 1980

6. PROFESSIONAL EXPERIENCE AND POSITIONS

• 1992-1996 Director, Continued Medical Education, Trenton Memorial Hospital
• 1989-1992 Director, Intensive Care Unit, Trenton Memorial Hospital
• 1985-1988 Lecturer, Faculty of Medicine, University of Manitoba
• 1984-1988 Consultant Internal Medicine and Endocrinology, Winnipeg Clinic
• 1985-1988 Active Staff, Victoria General Hospital, Winnipeg, Manitoba
• 1985-1988 Consultant, Internal Medicine, Health Sciences Centre, Winnipeg, Manitoba

7. POST-GRADUATE TRAINING

• 1983-1984 Chief Resident, Endocrinology and Metabolism, Ottawa Civic Hospital, University of Ottawa
• 1980-1983 Resident, Internal Medicine, Faculty of Medicine, University of Western Ontario, London
• 1978-1980 Clinical Research Fellow and Graduate Student in Clinical Pharmacology, Department of Pharmacology and Toxicology, University of Western Ontarion, London
• 1977-1978 Teaching Assistant, Departments of Medicine and Pharmacology, University of Ghana Medical School, Accra, Ghana

8. SOCIAL ACTIVITIES

• Member of the Board of Governors' National Council of Ghanaian Canadians
• Guest Medical Columnist, Ghanaian News Publication, Toronto, Ontario

9. HOBIES

• Golf
• Surfing the net (especially Amanfoo Website)

10. PUBLICATIONS

I. Original Articles

• Twum-Barima, Y., A Study of the central respiratory effects of four beta-adrenergic blocking drugs: MSc Thesis, University of Western Ontario, April 1981.
• Twum-Barima, Y., and Carrunthers, S.G., Quinidine-Rafampin Interaction. New England Journal of Medicine 304 (24) 1466-1469, 1981.
• Twum-Barima, Y., Ahmad, D., Hamilton, J.T. and Carruthers, S.G., Lack of effect of beta-adrenergic blocking drugs on the hyperventilatory response to carbon dioxide in normal subjects. Clinical Pharmacology & Therapeutics 32:289-294, 1982.
• Carruthers, S.G., Twum-Barima, Y., Measurements of Partial Agonist Activity of Pindolol in Man. Clinical Pharmacology & Therapeutics, 30:581-586, 1981.
• Klein, G.J., Twum-Barima, Y., Gulamhusein, S., Carruthers, S.G., Jarvis, R.T and Doner, A.P., Verapamil in Chronic Atrial Fibrillation: Pharmacokinetics and variable Patterns of Response. Clin. Cardiol. 7, 474-483, 1984.
• Clague, H.W., Twum-Barima, Y., and Carrunthers, S.G. An audit requests for Therapeutic Drug Monitoring of Digoxin: Problems and Pitfalls. Ther. Drug Monitoring 5: 249-254, 1983.

II. Case Reports

• Ooi, T.C., Twum-Barimah, Y. Rebound evaluation of cortisol following cyproheptadine withdrawal in Cushing's Disease from a pituitary macroadenoma. J. Endocrinol. Invest., 10:107, 1987

III. Review Article(s)

• Twum-Barima, Y., and Gay, John: Hyperparathyroidism and Hypoparathyroidism: Medicine North America: 15:1932-1937, 1984

IV. Abstracts

• Twum-Barima, Y., and Carrunthers, S.G. Evaluation of rifampinquinidine interaction. Clinical Pharm. Ther. 27 (2), 290, 180
• Twum-Barima, Y., Ahmad, D., McCall, B., and Carruthers, S.G. Cardiac and central respiratory effects of pinodolol. Proc. World Congress. Clinical Pharmacology 9742, 1980.
• Twum-Barima, Y. and Caruthers, S.G. Assessment of partial agonist activity of pindolol by evaluation of metaprolol-pindolol interaction. Clin. Res. 28(3), 667A, 1980.
• Twum-Barima, Y., Ahmad, D., McCall, B., and Carruthers, S.G. Cardiac and central respiratory effects of 4 beta-adrenoceptor blocking drugs. Clin. Res. 28 (3) 667A, 1980.
• Twum-Barima, Y., and Carrunthers, S.G. Increased clearance of oral and intravenous quinidine by rifampin. Clin. Res. 28 (3), 667A, 1980.
• Clague, H.S., Twum-Barima, Y., and Carruthers, S.G. Audit of the use of serum digoxin measurements. Annals RCPSC., Vol. 14, No. 3, June, 1981

V. Letter(s) to Editor

• Twum-Barima, Y., Finnigan, T., Habash, A.I., Cape, R.D.T. and Carruthers, S.G.: Impaired Enzyme induction by rifampin in the elderly. British Journal of Clinical Pharmacology 17:595-597, 1983

VI. Invited Lectures

• Canadian Diabetes Association, Guest Lecturer, Brandon Chaptor, "Human Insulins." 1984
• Visiting Professoro, Calgary General Hospital, "Therapeutic Drug Monitoring." October 1987
• Eli Lilly Company, Guest Speaker. "Role of New Insulins in Management of Diabetes Mellitus." Dryden Chapter, Canadian Diabetes Association. October, 1985
• Sandoz, Canda Ltd., Guest Speaker. Winkler, Manitoba. "Effects of antihypertensive drugs of Lipid Profiles." September 1986
• Visiting Lecturer, University of Ghana Medical School. "Innovations in Aetiology and Management of Diabetes Mellitus." July 1985.